Adenosine Kinase Inhibition Protects against Cranial Radiation-Induced Cognitive Dysfunction
Open Access
- 3 June 2016
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 9, 42
Abstract
Clinical radiation therapy for the treatment of CNS cancers leads to unintended and debilitating impairments in cognition. Radiation-induced cognitive dysfunction is long lasting, however, the underlying molecular and cellular mechanisms are still not well established. Since ionizing radiation causes microglial and astroglial activation, we hypothesized that maladaptive changes in astrocyte function might be implicated in radiation-induced cognitive dysfunction. Among other gliotransmitters, astrocytes control the availability of adenosine, an endogenous neuroprotectant and modulator of cognition, via metabolic clearance through adenosine kinase (ADK). Adult rats exposed to cranial irradiation (10 Gy) showed significant declines in performance of hippocampal-dependent cognitive function tasks (novel place recognition, novel object recognition, and contextual fear conditioning) 1 month after exposure to ionizing radiation using a clinically relevant regimen. Irradiated rats spent less time exploring a novel place or object. Cranial irradiation also led to reduction in freezing behavior compared to controls in the fear conditioning task. Importantly, immunohistochemical analyses of irradiated brains showed significant elevation of ADK immunoreactivity in the hippocampus that was related to astrogliosis and increased expression of glial fibrillary acidic protein (GFAP). Conversely, rats treated with the ADK inhibitor 5-iodotubercidin (5-ITU, 3.1 mg/kg, i.p., for 6 days) prior to cranial irradiation showed significantly improved behavioral performance in all cognitive tasks 1 month post exposure. Treatment with 5-ITU attenuated radiation-induced astrogliosis and elevated ADK immunoreactivity in the hippocampus. These results confirm an astrocyte-mediated mechanism where preservation of extracellular adenosine can exert neuroprotection also against radiation-induced pathology. These innovative findings link radiation-induced changes in cognition and CNS functionality to altered purine metabolism and astrogliosis, thereby linking the importance of adenosine homeostasis in the brain to radiation injury.Keywords
Funding Information
- National Institutes of Health (R01 MH083973, 1R21 NS088024)
- University of California (19900)
- Institute of Clinical and Translational Sciences (KL2TR001416)
This publication has 59 references indexed in Scilit:
- Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesisJournal of Clinical Investigation, 2013
- Characterizing the Radioresponse of Pluripotent and Multipotent Human Stem CellsPLOS ONE, 2012
- Human Neural Stem Cell Transplantation Ameliorates Radiation-Induced Cognitive DysfunctionCancer Research, 2011
- Astroglial networks scale synaptic activity and plasticityProceedings of the National Academy of Sciences, 2011
- Therapeutic epilepsy research: From pharmacological rationale to focal adenosine augmentationBiochemical Pharmacology, 2009
- Rescue of radiation-induced cognitive impairment through cranial transplantation of human embryonic stem cellsProceedings of the National Academy of Sciences, 2009
- Adenosine signaling and function in glial cellsCell Death & Differentiation, 2009
- Epilepsy and Cognitive Impairments in Alzheimer DiseaseArchives of Neurology, 2009
- Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s diseaseActa Neuropathologica, 2009
- Adenosine as a neuromodulator in neurological diseasesCurrent Opinion in Pharmacology, 2008